A vascular endothelial growth factor deficiency characterises scleroderma lung disease

Annals of the Rheumatic Diseases

Volumn 71, Issue 9, 2012, Pages 1461-1465

  De Santis, Maria ^a   Bosello, Silvia Laura ^a   Capoluongo, Ettore ^a   Inzitari, Rosanna ^a   Peluso, Giusy ^a   Lulli, Paola ^a   Zizzo, Gaetano ^a   Bocci, Mario ^a   Tolusso, Barbara ^a   Zuppi, Cecilia ^a   Castagnola, Massimo ^a   Ferraccioli, Gianfranco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG FLUID; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SCLERODERMA; SYSTEMIC SCLEROSIS; UPREGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR DEFICIENCY;

BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SCLERODERMA, SYSTEMIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864867270     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200657     Document Type: Article

References (26)

1. Mura M, dos Santos CC, Stewart D, et al. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol 2004;97:1605-17. (Pubitemid 39425973)
2. Kaner RJ, Crystal RG. Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 2001;7:240-6. (Pubitemid 33701923)
3. Maitre B, Boussat S, Jean D, et al. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. Eur Respir J 2001;18:100-6. (Pubitemid 32720382)
4. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002;166:1332-7. (Pubitemid 35292698)
5. Koyama S, Sato E, Haniuda M, et al. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002;166:382-5. (Pubitemid 34864431)
6. Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000;135:332-8. (Pubitemid 30213549)
7. Meyer KC, Cardoni AL, Xiang Z, et al. Vascular endothelial growth factor in human lung transplantation. Chest 2001;119:137-43. (Pubitemid 32150558)
8. Distler O, Del Rosso A, Giacomelli R, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002;4:R11.
9. Distler O, Distler JH, Scheid A, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004;95:109-16. (Pubitemid 38931842)
10. Davies CA, Jeziorska M, Freemont AJ, et al. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol 2006;37:190-7. (Pubitemid 43099839)
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
12. American Thoracic Society. Standardisation of spirometry - 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
13. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor). Recommendation for a standard technique - 1995 update. Am J Respir Crit Care Med 1995;152:2185-98.
14. Egan JJ, Martinez FJ, Wells AU, et al. Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification. Thorax 2005;60:270-3. (Pubitemid 40522359)
15. Behr J, Furst DE. Pulmonary function tests. Rheumatology (Oxford) 2008;47 (Suppl 5):v65-7.
16. De Santis M, Bosello S, La Torre G, et al. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis. Respir Res 2005;6:96.
17. Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003;29:255-73.
18. De Santis M, Bosello SL, Peluso G, et al. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J 2012;6:9-17.
19. Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
20. Dargaville PA, South M, Vervaart P, et al. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999;160:778-84. (Pubitemid 29442008)
21. Ferrero S. Is measurement of serum vascular endothelial growth factor reliable in patients with systemic sclerosis? J Rheumatol 2004;31:1468. (Pubitemid 38879223)
22. Capoluongo E, Vento G, Ameglio F, et al. Increased levels of IGF-1 and beta2-microglobulin in epithelial lining fluid of preterm newborns developing chronic lung disease. effects of rhG-CSF. Int J Immunopathol Pharmacol 2006;19:57-66.
23. Ebina M, Shimizukawa M, Shibata N, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:1203-8. (Pubitemid 38680397)
24. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004;170:242-51. (Pubitemid 38971408)
25. Stockmann C, Kerdiles Y, Nomaksteinsky M, et al. Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis. Proc Natl Acad Sci U S A 2010;107:4329-34.
26. McKeown S, Richter AG, O'Kane C, et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J 2009;33:77-84.